SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: margie who wrote (4253)5/6/1998 10:50:00 PM
From: Zirdu  Respond to of 6136
 
Here's the part I like (J Kernan asking about buyouts in the biotech arena)

" You might be a buyer I guess, instead of a seller?

Peter Johnson: Well, we have no immediate designs on either Glaxo or Smith Kline Beecham or other companies at this moment....."

Whew. Glad to know Agouron is not planning a hostile takeover of Glaxo!

RR



To: margie who wrote (4253)5/7/1998 12:20:00 AM
From: billkirn  Respond to of 6136
 
Margie: I must say I felt a strong feeling of emotion during the CNBC interview, when the closing remarks by... "Haines: Mr. Johnson, Thank you very much and I can confidently say that everyone's prayers are with you to succeed."
I felt a sense that Agouron is doing the job properly and with grace. They are going to significantly contribute to saving many lives and families. The by product of this focus will be a good financial return and a growing company.
Bill


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News